Post A Reply

Rate Inspire Medical Systems

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Hot Ticker Articles

MiMedx CEO Gets Called Out By Short Seller at JPM Healthcare Conference

3 sales tips to get off to a fast start in 2018

The Top 10 Medtechy Articles From 2017

Has Titan Medical missed their opportunity with SPORT?

Can Instagram Be MannKind Afrezza's Best Marketing Tool?

Job Listings

More big news - smaller, thinner, longer lasting device and new publications

Sleep Tech Will Widen the Gap Between the Rich and the Poor - Sleep Review

Some experts believe that sleep reduction gadgets will intensify the planet’s income inequality problem, reports Motherboard.

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

Insurance challenges have prevented Inspire from raising more money.

I think Inspire presented at the JPM Morgan meeting. Good sign for them. I thought the company was dead.

post

Are they done? I know of a couple of reps who've been there and left.

I have written book and will tell you all about experience.


post

Insurance challenges have prevented Inspire from raising more money.

Are they done? I know of a couple of reps who've been there and left.

post

not sure what mdt's position is, but other suitors exist. JNJ is invested as well. The therapy works very well, the pt population (unwilling/unable to tolerate CPAP) is not insignificant, and the awareness of the consequences of unaddressed OSA continues to rise. Surpassing 1000 cases is impressive considering most have come after multi-level pre-d appeals, which means payers are losing the appeal battle which costs the payers money. If the competition comes out with good data, the payers won't be able to continue claiming investigational as a reason for denial.

Insurance challenges have prevented Inspire from raising more money.

post

not sure what mdt's position is, but other suitors exist. JNJ is invested as well. The therapy works very well, the pt population (unwilling/unable to tolerate CPAP) is not insignificant, and the awareness of the consequences of unaddressed OSA continues to rise. Surpassing 1000 cases is impressive considering most have come after multi-level pre-d appeals, which means payers are losing the appeal battle which costs the payers money. If the competition comes out with good data, the payers won't be able to continue claiming investigational as a reason for denial.

Who is the comp?

post

I've heard a number of reps have left over the years and Medtronic no longer interested in the company or re-investing.

not sure what mdt's position is, but other suitors exist. JNJ is invested as well. The therapy works very well, the pt population (unwilling/unable to tolerate CPAP) is not insignificant, and the awareness of the consequences of unaddressed OSA continues to rise. Surpassing 1000 cases is impressive considering most have come after multi-level pre-d appeals, which means payers are losing the appeal battle which costs the payers money. If the competition comes out with good data, the payers won't be able to continue claiming investigational as a reason for denial.

post

The only difference is now it is MRI compatible? Not enough change to make a difference for a product that has such a small patient market. Sorry.

Nice read

post

The only difference is now it is MRI compatible? Not enough change to make a difference for a product that has such a small patient market. Sorry.

I've heard a number of reps have left over the years and Medtronic no longer interested in the company or re-investing.

post

For ease of reading, we have uploaded the document linked in the previous post.

Medtech[y]

Inspire Medical Systems Announces FDA Approval of Inspire 3028 Neurostimulator for the Treatment of OSA by medtechy on Scribd

The only difference is now it is MRI compatible? Not enough change to make a difference for a product that has such a small patient market. Sorry.

post

Loading...


Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.